Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III casopitant plus ondansetron and dexamethasone for prevention of cisplatin-induced nausea and vomiting
2006-002033-21Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of casopitant in chemotherapy-induced nausea and vomiting (CINV) (2 arms), sponsored by GSK. Primary endpoint: Complete response over 120 hours. Started Jun 2006; status: completed.
02
Drugs
casopitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on 2006-002033-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002033-21.